CN118891273A - 膜联蛋白a1衍生的多肽类似物 - Google Patents
膜联蛋白a1衍生的多肽类似物 Download PDFInfo
- Publication number
- CN118891273A CN118891273A CN202380023372.3A CN202380023372A CN118891273A CN 118891273 A CN118891273 A CN 118891273A CN 202380023372 A CN202380023372 A CN 202380023372A CN 118891273 A CN118891273 A CN 118891273A
- Authority
- CN
- China
- Prior art keywords
- lys
- polypeptide
- seq
- amino acid
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4721—Lipocortins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22158253 | 2022-02-23 | ||
| EP22158253.9 | 2022-02-23 | ||
| PCT/EP2023/054519 WO2023161323A1 (en) | 2022-02-23 | 2023-02-23 | Annexin a1-derived polypeptide analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118891273A true CN118891273A (zh) | 2024-11-01 |
Family
ID=80461005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202380023372.3A Pending CN118891273A (zh) | 2022-02-23 | 2023-02-23 | 膜联蛋白a1衍生的多肽类似物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250388632A1 (https=) |
| EP (1) | EP4482853A1 (https=) |
| JP (1) | JP2025506775A (https=) |
| CN (1) | CN118891273A (https=) |
| AU (1) | AU2023226134A1 (https=) |
| CA (1) | CA3249181A1 (https=) |
| WO (1) | WO2023161323A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025083393A1 (en) * | 2023-10-16 | 2025-04-24 | Therakind Limited | Antimicrobial use of peptides derived from annexin a1 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002364607A1 (en) * | 2001-12-28 | 2003-07-24 | The Burnham Institute | Novel ligand involved in the transmigration of leukocytes . |
| FR2856069A1 (fr) * | 2003-06-10 | 2004-12-17 | Bionexis | Molecules de ciblage et de liberation de composes therapeutiques et leur utilisation |
| US9102753B2 (en) | 2011-06-15 | 2015-08-11 | Ugp Therapeutics, Inc. | Anti-inflammatory pharmaceutical products |
| KR20150029457A (ko) * | 2013-09-10 | 2015-03-18 | 삼성전자주식회사 | 아넥신 a1에 결합하는 폴리펩타이드 및 그의 용도 |
| JP2017513875A (ja) | 2014-04-22 | 2017-06-01 | ティーエックスピー ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 分枝状アミノ酸プローブを有するペプチド類似体 |
-
2023
- 2023-02-23 CN CN202380023372.3A patent/CN118891273A/zh active Pending
- 2023-02-23 AU AU2023226134A patent/AU2023226134A1/en active Pending
- 2023-02-23 EP EP23706360.7A patent/EP4482853A1/en active Pending
- 2023-02-23 CA CA3249181A patent/CA3249181A1/en active Pending
- 2023-02-23 US US18/839,672 patent/US20250388632A1/en active Pending
- 2023-02-23 WO PCT/EP2023/054519 patent/WO2023161323A1/en not_active Ceased
- 2023-02-23 JP JP2024549631A patent/JP2025506775A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023226134A1 (en) | 2024-08-01 |
| EP4482853A1 (en) | 2025-01-01 |
| US20250388632A1 (en) | 2025-12-25 |
| WO2023161323A1 (en) | 2023-08-31 |
| JP2025506775A (ja) | 2025-03-13 |
| CA3249181A1 (en) | 2023-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230295255A1 (en) | Annexin a1-derived polypeptide analogues | |
| US5620955A (en) | Bombesin receptor antagonists and uses thereof | |
| CN104822702B (zh) | α-MSH和γ-MSH类似物 | |
| NZ265452A (en) | Analogues of peptide yy, dimers and pharmaceutical compositions | |
| EA036406B1 (ru) | Аналоги глюкагона | |
| CZ293113B6 (cs) | Peptidový derivát | |
| JPH06503090A (ja) | ノナペプチドのボンベシン拮抗薬 | |
| WO2023165476A1 (zh) | 针对sort1的多肽化合物及其药物偶联物 | |
| JP2007526240A (ja) | ブラジキニンb1受容体の拮抗薬 | |
| EP0574530A1 (en) | Endothelin antagonists | |
| WO2015162483A1 (en) | Alpha- and gamma-msh analogues | |
| US20150376254A1 (en) | Gamma-msh analogues | |
| KR100251496B1 (ko) | 헥사펩티드 | |
| CN118891273A (zh) | 膜联蛋白a1衍生的多肽类似物 | |
| US5736517A (en) | Treatment of cancer with peptides | |
| CA2507616A1 (en) | Highly stable pacap/vip-derived peptides | |
| WO2017068020A1 (en) | W-peptide analog | |
| CN113024635B (zh) | 一类订书肽化合物及其药物组合物的用途 | |
| JP2001226284A (ja) | 神経突起誘発剤 | |
| TWI237029B (en) | Vasoactive intestinal peptide analogs | |
| US6989371B1 (en) | Bombesin analogs for treatment of cancer | |
| CN116390938A (zh) | 毒蜥外泌肽-4类似物 | |
| JP3040166B2 (ja) | ノナペプチドのボンベシン拮抗薬 | |
| WO2008050161A2 (en) | Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds | |
| JPH09512787A (ja) | ペプシンの放出を抑制するためのペプチド |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |